ロード中...

Erythroid Promoter Confines FGF2 Expression to the Marrow after Hematopoietic Stem Cell Gene Therapy and Leads to Enhanced Endosteal Bone Formation

Fibroblast growth factor-2 (FGF2) has been demonstrated to be a promising osteogenic factor for treating osteoporosis. Our earlier study shows that transplantation of mouse Sca-1(+) hematopoietic stem/progenitor cells that are engineered to express a modified FGF2 leads to considerable endosteal/tra...

詳細記述

保存先:
書誌詳細
主要な著者: Meng, Xianmei, Baylink, David J., Sheng, Matilda, Wang, Hongjie, Gridley, Daila S., Lau, K.-H. William, Zhang, Xiao-Bing
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3356341/
https://ncbi.nlm.nih.gov/pubmed/22629419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0037569
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!